Courtesy of dsm-firmenich
dsm-firmenich, a leading innovator in nutrition, health, and beauty, today announces a breakthrough in dairy cultures that aims to transform fermentation performance across the food industry. In collaboration with APC Microbiome Ireland, a world-leading Research Ireland Center at University College Cork, and the French National Research Institute for Agriculture, Food and Environment (INRAE), dsm-firmenich has uncovered how bacteria used in dairy fermentations employ and activate defense systems against bacteriophages. Otherwise known as phages, these bacterial viruses can impact the production of cheese, yogurt, and other fermented dairy products and therefore require strict and costly management. Published in the Proceedings of the National Academy of Sciences (PNAS), the findings unlock new opportunities to design more resilient, high-performing cultures for large-scale food production.
Revealing the science behind dairy fermentation resilience
By investigating 13 newly-discovered antiphage systems in Lactococcus lactis—the primary bacterial species used in dairy fermentations—researchers revealed how these cultures recognize and respond to phage exposure, and how phages evolve to bypass these defenses. Through genomic analysis of 66 phage mutants that had successfully overcome bacterial resistance, the team identified 15 viral genes involved in this evasion process. These insights into diverse escape strategies reveal, in molecular detail, how phages outmaneuver bacterial defenses—and how those adaptations can be anticipated and countered.
Among the most compelling discoveries is the characterization of a novel defense system known as Audmula. This mechanism protects bacterial cultures by modifying the host’s cell wall, effectively trapping the phage inside and preventing its spread throughout the fermentation. It’s the first time this mode of action has been observed—introducing a previously undocumented strategy that could significantly strengthen culture protection.
From breakthrough to benefit: redefining culture protection in dairy
Bacteriophage outbreaks remain one of the most costly and disruptive challenges in industrial dairy production, leading to stalled fermentation, lost batches, and compromised product quality. The knowledge gained from this research marks a major advancement in understanding how culture blends and culture rotations can be developed to ensure optimal protection against phage contamination. dsm-firmenich will incorporate these new insights into its culture development toolbox to support the delivery of more tailored, phage-robust culture solutions.
“Over the past decade, we’ve learned that bacterial antiviral defenses form an arsenal far more diverse and complex than we ever imagined,” said Prof. Douwe van Sinderen, senior author of the study. “With this study, we’re finally beginning to understand how those defenses function—and how viruses manage to evade them. In practical terms, these findings pave the way for next-generation starter cultures designed to withstand the phage challenges facing today’s dairy fermentations.”
A model for industry–academia collaboration
dsm-firmenich played a pivotal role in bridging academic discovery with industrial application. By providing proprietary Lactococcus strains, comprehensive genomic data, and phages sourced from live dairy environments, the company ensured that the research was grounded in real-world conditions. These contributions enabled the academic team’s discoveries and conclusions that were both scientifically cutting-edge and commercially relevant.
“By decoding the complex relationship between cultures and phages, we’re turning cutting-edge science into competitive advantage—giving us the tools to design ultra-robust culture blends and rotation schemes, empowering producers to take control of fermentation across dairy, plant-based, probiotics, and emerging biotechnologies,” said Noël van Peij, co-author and principal scientist at dsm-firmenich. “This is science delivering value for the cheese and fermented milk products market, where it matters most.”
Evandro Oliveira de Souza, global senior vice-president cheese business unit at dsm-firmenich added, “These findings demonstrate the power of combining our in-house scientific expertise with world-class research partnerships to solve real industry challenges. By applying these insights to our culture development, we’re adding to the unique depth and breadth of our dairy portfolio and strengthening our ability to deliver more resilient and reliable fermentation performance for dairy producers worldwide.”
With over 50 years of experience in dairy, dsm-firmenich continues to lead the way in starter, bioprotective and probiotic cultures, enzymes, hydrocolloids, nutritional solutions, and quality assurance—helping producers deliver safe and great-tasting dairy products of consistent quality, worldwide.
“The great phage escape: Activating and escaping lactococcal antiphage systems” is published in PNAS and available here.
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
